Summary:
MediSpect Medical Research is conducting a randomized, double-blind (test products and placebo), chronic dosing (24 weeks), placebo-controlled, parallel group, multi-center study to assess the efficacy and safety of pt003, pt005, and pt001 in subjects with moderate to very severe Copd, compared with placebo.
Take the first step and see if you qualify.
Qualified Participants Must:
• Be between 40 and 80 years of age
•
Have a smoking history of 10 years or more
Qualified Participants May Receive:
Study related medical care, study medication,
compensation for time and travel.